MKVentures Capital Rights Issue 2023 vs Piramal Pharma Rights Issue 2023

Comparison between MKVentures Capital Rights Issue 2023 and Piramal Pharma Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for MKVentures Capital Rights Issue 2023 and Piramal Pharma Rights Issue 2023. MKVentures Capital Rights Issue 2023 is listed on BSE while Piramal Pharma Rights Issue 2023 is listed on BSE, NSE.

 MKVentures Capital LimitedPiramal Pharma Limited
LogoMKVentures Capital Rights Issue 2023 LogoPiramal Pharma Rights Issue 2023 Logo
Listing AtBSEBSE, NSE
Terms of PaymentFull Amount on ApplicationFull Amount on Application
Entitlement1 Rights Equity Share(s) for every 8 fully paid-up Equity Shares held on Record Date5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarMUFG Intime India Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead ManagersChoice Capital Advisors Pvt.Ltd.ICICI Securities Ltd.

Rights Issue Size and Price

The issue size of MKVentures Capital Rights Issue 2023 rights issue is ₹39.97 Crores, whereas Piramal Pharma Rights Issue 2023 rights issue size is ₹1,050.00 Crores.

 MKVentures Capital LimitedPiramal Pharma Limited
Issue Size4,27,050 shares12,96,29,630 shares
Issue Size (Amount)₹39.97 Crores₹1,050.00 Crores
Issue Price₹936 per share₹81 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of MKVentures Capital Rights Issue 2023 is Apr 04, 2023 while record date of Piramal Pharma Rights Issue 2023 is Aug 02, 2023.

 MKVentures Capital LimitedPiramal Pharma Limited
Record DateApr 04, 2023Aug 02, 2023
Credit of Rights EntitlementsApr 13, 2023
Bid/Offer Opens OnApr 17, 2023Aug 08, 2023
Renunciation of Rights EntitlementsApr 20, 2023Aug 10, 2023
Bid/Offer Closes OnApr 25, 2023Aug 17, 2023
Deemed Date of AllotmentMay 03, 2023Aug 23, 2023
Credit DateMay 04, 2023Aug 24, 2023
Listing DateMay 08, 2023Aug 28, 2023

Financials details

Comparison of MKVentures Capital Rights Issue 2023 and Piramal Pharma Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 MKVentures Capital LimitedPiramal Pharma Limited
Financial
MKVentures Capital Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxReserves and Surplus
31-Mar-208.671.58-1.470.02
31-Mar-2111.868.312.700.02
31-Mar-2215.5013.724.570.02
Amount in ₹ Crore
Piramal Pharma Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets10,899.7812,797.0414,522.56
Revenue6,479.016,834.907,306.66
Profit After Tax835.03375.96-186.46
Net Worth5,076.756,069.945,968.45
Reserves and Surplus4,488.625,290.695,181.79
Total Borrowing2,910.194,023.285,504.77
Amount in ₹ Crore

Compare with others

Compare:

MKVentures Capital Rights Issue 2023 Vs Piramal Pharma Rights Issue 2023